Patents by Inventor Peter Moonen

Peter Moonen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130157073
    Abstract: A bi-metallic component including a first member of a first metal and a second member of a second metal different than the first metal. The first member includes at least one perforation. The second member is directly cast-in-place about a sheet-like portion of the first member and through the perforation to rigidly secure the first and second members. When used in an automotive vehicle, the second metal of the second member is preferably of aluminum and the first metal of the first member is preferably a high strength steel for spot welding to other steel structures.
    Type: Application
    Filed: June 10, 2011
    Publication date: June 20, 2013
    Inventors: Pascal Paul Charest, Gregor Leopold Babic, Peter Moonen, Eric Albertus deNijs
  • Patent number: 8067357
    Abstract: The present invention provides methods and compositions for the treatment and diagnosis of diseases such as neoplastic diseases, neurodegenerative diseases, cardiovascular diseases, autoimmune diseases, and inflammatory diseases. The methods are based on the concept of pretargeting and include the administration of complexes comprising a recognizable compound A coupled to annexins, and the administration of complexes comprising of pharmaceutical or diagnostic compounds coupled to a compound B recognizing and binding to compound A to subjects. The compositions include annexins, annexin variants, that are not internalized by the target cells, derivatives thereof, and complexes thereof.
    Type: Grant
    Filed: December 12, 2006
    Date of Patent: November 29, 2011
    Assignee: Mosamedix B.V.
    Inventors: Christiaan Peter Maria Reutelingsperger, Peter Moonen, Ad Vermaire
  • Publication number: 20090155170
    Abstract: The present invention provides methods and compositions for the treatment and diagnosis of diseases such as neoplastic diseases, neurodegenerative diseases, cardiovascular diseases, autoimmune diseases, and inflammatory diseases. The methods are based on the concept of pretargeting and include the administration of complexes comprising a recognizable compound A coupled to annexins, and the administration of complexes comprising of pharmaceutical or diagnostic compounds coupled to a compound B recognizing and binding to compound A to subjects. The compositions include annexins, annexin variants, that are not internalized by the target cells, derivatives thereof, and complexes thereof.
    Type: Application
    Filed: December 12, 2006
    Publication date: June 18, 2009
    Inventors: Christiaan Peter Maria Reutelingsperger, Peter Moonen, Ad Vermaire